Membrane proteins as diagnostic biomarkers and targets for new therapies

Current Opinion in Molecular Therapeutics

Volumn 10, Issue 2, 2008, Pages 116-123

  Josic, D ^a,b   Clifton, J G ^a,b   Kovac, S ^c   Hixson, D C ^a,b  

^a RHODE ISLAND HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

Author keywords

Cancer treatment; Disease biomarker; Membrane protein

Indexed keywords

MEMBRANE PROTEIN;

CANCER THERAPY; CELL POPULATION; MEMBRANE MICROPARTICLE; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEOMICS; REVIEW;

BIOLOGICAL MARKERS; HUMANS; MEMBRANE PROTEINS; NEOPLASMS; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 41849114925     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (80)

1. Polanski M, Anderson NA: A list of candidate cancer biomarkers for targeted proteomics. Biomarker Insights (2006) 2:1-48. • A list of candidate biomarkers is presented, a significant fraction of which are membrane and membrane-associated proteins.
2. Josic D, Clifton JG: Mammalian plasma membrane proteomics. Proteomics (2007) 7(16):3010-3029. • A review on plasma membrane proteomics with a focus on their separation and identification.
3. Bernas T, Grégori G, Asem EK, Robinson JP: Integrating cytomics and proteomics. Mol Cell Proteomics (2006) 5(1):2-13.
4. Wang W, Guo T, Rudnick PA, Song T, Li J, Zhuang Z, Zheng W, DeVoe DL, Lee CS, Balgley BM: Membrane proteome analysis of microdissected ovarian tumor tissues using capillary isoelectric focusing/reversed-phase liquid chromatography-tandem MS. Anal Chem (2007) 79(3):1002-1009. • This study identified membrane proteins from microdissected cancer tissue. As few as 20,000 cells were sufficient for their identification.
5. Dainiak MB, Kumar A, Galaev IY, Mattiasson B: Detachment of affinitycaptured bioparticles by elastic deformation of a macroporous hydrogel. Proc Natl Acad Sci USA (2006) 103(4):849-854.
6. Kalashnikova I, Ivanova N, Tennikova T: Macroporous monolithic layers as efficient 3-D microarrays for quantitative detection of virus-like particles. Anal Chem (2007)79(14):5173-5180.
7. Schindler J, Nothwang HG: Aqueous two-phase systems: Effective tools for plasma membrane proteomics. Proteomics (2006) 6(20):5409-5417.
8. Lawson E, Brown MK, Huang F, Callanan H, Rucevic M, Nicoletti A, Clifton J, Hixson D, Josic D: Use of magnetic beads with immobilized monoclonal antibodies for isolation of highly pure plasma membranes. Electrophoresis (2006) 27(13):2747-2758.
9. Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, Testa JE, Schnitzer JE: Subtractive proteomic mapping of the endothelial surface in lung solid tumors for tissue-specific therapy. Nature (2004) 429(6992):629-635.
10. Zhao Y, Zhang W, Kho Y, Zhao Y: Proteomic analysis of integral plasma membrane proteins. Anal Chem (2004) 76(7):1817-1823. • This study combined surface biotinylation and biotin/avidin affinity purification with selective extraction as an effective method for the isolation of membrane proteins.
11. Li X, Cao J, Jin Q, Xie C, He Q, Cao R, Xiong J, Chen P, Wang X, Liang S: A proteomic study reveals the diversified distribution of plasma membrane-associated proteins in rat hepatocytes. J Cell Biochem (2008):doi 10.1002/jcb.21680.
12. Barile M, Pisitkun T, Yu MJ, Chou CL, Verbalis M, Shen RF, Knepper MA: Large scale protein identification in intracellular aquaporin-2 vesicles from renal inner medulary collecting duct. Mol Cell Proteomics (2005) 4(8):1095-1106.
13. Cutillas PR, Biber J, Marks J, Jacob R, Stieger B, Cramer R, Waterfield M, Burlingame AL, Unwin RJ: Proteomic analysis of plasma membrane vesicles isolated from rat renal cortex. Proteomics (2005) 5(1):101-112.
14. Durr E, Yu J, Krasinska KM, Carver LA, Yates JR, Testa JE, Oh P, Schnitzer JE: Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nature Biotechnol (2004) 22(8):985-992.
15. Blonder J, Chan KC, Issaq HJ, Veenstra TD: Identification of membrane proteins from mammalian cell/tissue using methanol-facilitated solubilization and tryptic digestion coupled with 2D-LC-MS/MS. Nature Protocols (2006) 1(6):2784-2790.
16. Le Naour F, André M, Boucheix C, Rubinstein E: Membrane microdomains and proteomics: Lessons from tetraspanin microdomains and comparison with lipid rafts. Proteomics (2006) 6(24):6447- 6454.
17. Sprenger RR, Horrevoets AJG: The ins and outs of lipid domain proteomics. Proteomics (2007) 7(16):2895-2903. • An overview of lipid rafts and other plasma membrane microdomains.
18. Foster LJ, de Hoog CL, Zhang Y, Zhang Y, Xie X, Mootha VK, Mann M: A mammalian organelle map by protein correlation profiling. Cell (2006) 125(1):187-199. • This study used protein correlation profiling to map 1404 proteins to ten subcellular locations in mouse liver.
19. Senis YA, Tomlinson MG, García A, Dumon S, Heath VL, Herbert J, Cobbold SP, Spalton JC, Ayman S, Antrobus R, Zitzmann et al: A comprehensive proteomics and genomics analysis reveals novel transmembrane proteins in human platelets and mouse megakaryocytes including G6-B, a novel immunoreceptor tyrosine-based inhibitory motif protein. Mol Cell Proteomics (2007) 6(3):548-564. • Novel human platelet and mouse megakaryocyte membrane proteins were identified using proteomics and genomics approaches.
20. Wu L, Hwang SI, Rezaul K, Lu LJ, Mayya V, Gerstein M, Eng JK, Lundgren DH, Han DK: Global survey of human T leukemic cells by integrating proteomics and transcriptomic profiling. Mol Cell Proteomics (2007) 6(8):1343-1353.
21. Jansson M, Wårell K, Levander F, James P: Membrane protein identification: N-terminal labeling of nontryptic membrane protein peptides facilitates database searching. J Proteome Res (2008) 7(2):659-665. • Membrane proteins with up to 21 TMDs were identified using this method.
22. Carroll J, Altman MC, Fearnley IM, Walker JE: Identification of membrane proteins by tandem mass spectrometry of protein ions. Proc Natl Acad Sci USA (2007) 104(36):14330-14335. • An optimized method for the purification and identification of hydrophobic protein.
23. Martosella J, Zolotarjova N, Liu H, Moyer SC: High recovery HPLC separation of lipid rafts for membrane proteome analysis. J Proteome Res (2006) 5(6):1301-1312.
24. Krueger KE, Srivastava S: Posttranslational protein modifications: Current implications for cancer detection, prevention and therapeutics. Mol Cell Proteomics (2006) 5(10):1799-1810. • Changes in PTMs important for the diagnosis and treatment of cancer are reviewed. Differences in protein phosphorylation, acetylation, methylation, prenylation ubiquitination, sumoylation, glycosylation and other forms of PTMs are discussed.
25. Block TM, Comunale MA, Lowman M, Steel LF, Romano P, Fimmel C, Tennant BC, London WT, Evans AA, Blumberg BS, Dwek RA et al: Use of targeted glycoproteomics to identify serum glycoproteins that correlate with liver cancer in woodchucks and humans. Proc Natl Acad Sci USA (2005) 102(3):779-784.
26. Drake, RR, Schwegler EE, Malik G, Diaz J, Blocks T, Mehta A, Semme OJ: Lectin capture strategies combined with mass spectrometry for the discovery of serum glycoprotein biomarkers. Mol Cell Proteomics (2006) 5(10):1957-1967.
27. Zhang H, Loriaux P, Eng J, Campbell D, Keller A, Moss P, Bonneau R, Zhang N, Zhou Y, Wollscheid B, Cooke K et al: UniPep - a database for human N-linked glycosites: A resource for biomarker discovery. Genome Biol (2006) 7(8):R73.
28. Polley ACJ, Mulholland F, Pin C, Williams EA, Bradburn DM, Mills SJ, Mathers JC, Johnson IT: Proteomic analysis reveals field-wide changes in protein expression in the morphologically normal mucosa of patients with colorectal neoplasia. Cancer Res (2006) 66(13):6553-6562.
29. Dube DH, Prescher JA, Quang CN, Bertozzi CR: Probing mucin-type O-linked glycosylation in living animals. Proc Natl Acad Sci USA (2006) 103(13):4819-4824.
30. Zhang H, Liu AY, Loriaux P, Wollscheid B, Zhou Y, Watts JD, Aebersold R: Mass spectrometric detection of tissue proteins in plasma. Mol Cell Proteomics (2007) 6(1):64-71. • Plasma membrane antigens were identified by MS in both plasma and tissue specimens.
31. Zarling A, Polefrone JM, Evans AM, Mikesh LM, Shabanowitz J, Lewis ST, Engelhard VH, Hunt DF: Identification of class I MHC-associated phosphopeptides as targets for cancer immunotherapy. Proc Natl Acad Sci USA (2006) 103(40):14889-14894. • Alterations in the phosphorylation of cellular proteins in malignant cells were investigated and cancer-associated phosphopeptides were identified.
32. Wolf-Yadlin A, Hautaniemi S, Lauffenburger DA, White FM: Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks. Proc Natl Acad Sci USA (2007) 104(14):5860-5865.
33. Kim JE, White FM: Quantitative analysis of phosphotyrosine signaling networks triggered by CD3 and CD28 costimulation in Jurkat cells. J Immunol (2006) 176(5):2833-2843.
34. Witze ES, Old WM, Resing KA, Ahn NG: Mapping protein posttranslational modifications with mass spectrometry. Nat Methods (2007) 4(10):798-806. • The use of MS for mapping PTMs of proteins is reviewed. In addition, different approaches for detection, characterization and quantification of protein PTMs are discussed.
35. Jeon HB, Choi ES, Yoon JH, Hwang JH, Chang JW, Lee EK, Choi HW, Park ZY, Yoo YJ: A proteomics approach to identify ubiquitinated proteins in mouse heart. Biochem Biophys Res Commun (2007) 357(3):731-736.
36. Jin M, Drwal G, Bourgeois T, Saltz J, Wu HM: Distinct proteome features of plasma microparticles. Proteomics (2005) 5(7):1940-1952. • Data on the plasma MP proteome are provided and form a basis for proteomic studies searching for biomarkers in these cell- and tissue derivedvesicles.
37. Janowska-Wieczorek A, Wysoczynski M, Kijowski J, Marquez-Curtis L, Machalinski B, Ratajczak J, Ratajczak MZ: Microvesicles derived from activated platelets induce metastasis and angiogenesis in lung cancer. Int J Cancer (2005) 113(5):752-760. • Membrane particles were observed to play an important role in lung cancer tumor growth, metastasis and angiogenesis.
38. Valenti R, Huber V, Filipazzi P, Pilla L, Sovena G, Villa A, Corbelli A, Fais S, Permiani G, Rivoltini L: Human tumor-released microvesicles promote the differentiation of myeloid cells with transforming growth factor-β-mediated suppressive activity on T lymphocytes. Cancer Res (2006) 66(18):9290-9298.
39. Miguet L, Pacaud K, Felden C, Hugel B, Martinez MC, Freyssinet J-M, Herbrecht R, Potier N, van Dorsselaer A, Mauvieux L: Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics (2006) 6(1):153-171. • Many pathology-associated membrane proteins were identified in malignant lymphoid cells.
40. Epstein JE, Giersing B, Mullen G, Moorthy V, Richie TL: Malaria vaccines: Are we getting closer? Curr Opin Mol Ther (2007) 9(1):12-24.
41. Cowman AF, Crabb BS: Invasion of red blood cells by malaria parasites. Cell (2006) 124(4):755-766. • The molecular mechanism of red cell invasion by malaria parasites is described. Out of 48 important parasite proteins, 24 are membrane or peripheral surface proteins.
42. Johnson JR, Florens R, Carucci DJ, Yates JR 3rd: Proteomics in malaria. J Proteome Res (2004) 3(2):296-306.
43. Gilson PR, Nebl T, Vukcevic D, Moritz RL, Sargaent T, Speed TP, Schofield L, Crabb BS: Identification and stoichiometry of glycosylphosphatidylinositol-anchored membrane proteins of human malaria parasite Plasmodium falciparum. Mol Cell Proteomics (2006) 5(7):1286-1299. • Proteomic analysis identified GPI-anchoring of surface proteins in the malaria parasite and computer software predicted additional GPI-anchored proteins.
44. Sinha S, Kosalai K, Arora S, Namane A, Sharma P, Gaikwad AN, Brodin P, Cole ST: Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology (2005) 151(7):2411-2419.
45. Mattow J, Siejak F, Hagens K, Becher D, Albrecht D, Krah A, Schmidt F, Jungblut PR, Kaufmann SHE, Schaible UE: Proteomics unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics (2006) 6(8):2485-2494.
46. Målen H, Berven FS, Fladmark KE, Wiker HG: Comprehensive analysis of exported proteins from Mycobacterium tuberculosis H37Rv. Proteomics (2007) 7(10):1702-1718. • A proteomic analysis of secreted Mycobacterium proteins was conducted and a significant portion of the identified proteins were integral or plasma membrane-associated proteins.
47. Berro R, de la Fuente C, Klase Z, Kehn K, Parvin L, Pumfery A, Abgottah E, Vertes A, Nekhai S, Kashanchi F: Identifying the membrane proteome of HIV-1 latently infected cells. J Biol Chem (2007) 282(11):8207-8218.
48. Boutwell CL, Essex M: Identification of HLA class I-associated amino acid polymorphisms in the HIV-1C proteome. AIDS Res Hum Retroviruses (2007) 23(1):165-174. • Proteomic methods were used to demonstrate the potential of HIV to escape cytotoxic lymphocyte attack.
49. Lin YF, Wu MS, Chang CC, Lin SW, Lin JT, Sun YJ, Chen DS, Chow LP: Comparative immunoproteomics of identification and chracterization of virulence factors from Helicobacter pylori related to gastric cancer. Mol Cell Proteomics (2006) 5(8):1484-1496. • Surface proteins of H pylori were probed in serum samples of patients with gastric cancer. Co-chaperonin GroES was identified as a novel virulence factor associated with gastric cancer.
50. Mannová P, Fang R, Wang H, Deng B, McIntosh MW, Hanash SM, Beretta L: Modification of host lipid raft proteome upon hepatitis C virus replication. Mol Cell Proteomics (2006) 5(12):2319-2325.
51. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK et al: A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med (2007) 356(1):11-20.
52. Herbst RS, Lippman SM: Molecular signatures of lung cancer - toward personalized therapy. N Engl J Med (2007) 356(1):76-78.
53. Hellstrom I, Raycraft J, Kanan S, Sardesai NY, Verch T, Yang Y, Hellstrom KE: Mesothelin variant 1 is released from tumor cells as a diagnostic marker. Cancer Epidemiol Biomarkers Prev (2006) 15(5):1014- 1020.
54. Simon I, Zhuo S, Corral L, Diamandis EP, Sarno MJ, Wolfert RL, Kim NW: B7-H4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer. Cancer Res (2006) 66(3):1570- 1575. • A sensitive mAb sandwich ELISA was developed to analyze levels of B7-H4 in serum, ascites fluids and tissue lysates.
55. Canelle L, Bousquet J, Pionneau C, Hardouin J, Choquet-Kastylevsky G, Joubert-Caron R, Caron M: A proteomic approach to investigate potential biomarkers directed against membrane-associated breast cancer proteins. Electrophoresis (2006) 27(8):1609-1616.
56. Filardo EJ, Graeber CT, Quinn JA, Resnick MB, Giri D, DeLellis RA, Steinhoff MM, Sabo E: Distribution of GPR30, a seven membranespanning estrogen receptor, in primary breast cancer and its association with clinicopathologic determinations of tumor progression. Clin Cancer Res (2006) 12(21):6359-6366.
57. Rajasekaran AK, Anilkumar G, Christiansen JJ: Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol (2005) 288(5):C975-C981. • The structure and possible function(s) of PSMA, and its role as a potential target for prostate cancer therapy were discussed.
58. Moffatt S, Papasakelariou C, Wiehle S, Cristiano R: Successful in vivo tumor targeting of prostate-specific membrane antigen with a highly efficient J591/PEI/DNA molecular conjugate. Gene Ther (2006) 13(9):761-772.
59. Chu TC, Marks JW 3rd, Lavery LA, Faulkner S, Rosenblum MG, Ellington AD, Levy M: Aptamer: Toxin conjugates that specifically target prostate tumor cells. Cancer Res (2006) 66(12):5989-5992.
60. Milowsky MI, Nanus DM, Kostakoglu L, Sheehan CE, Vallabhajosula S, Goldsmith SJ, Ross JS, Bander NH: Vascular targeted therapy with anti-prostate-specific membrane antigen monoclonal antibody J591 in advanced solid tumors. J Clin Oncol (2007) 25(5):540-547. • Preliminary data demonstrated that the anti-PSMA antibody can be used as a potential vascular targeting agent.
61. Neri D, Bicknell R: Tumour vascular targeting. Nat Rev Cancer (2005) 5(6):436-446. • Tumor endothelial markers as putative targets for cancer treatment were described.
62. Das S, Hahn Y, Nagata S, Willingham MC, Bera TK, Lee B, Pastan I: NGEP, a prostate-specific plasma membrane protein that promotes the association of LNCaP cells. Cancer Res (2007) 67(4):1594-1601.
63. Oh P, Borgström P, Witkiewicz H, Li Y, Borgström BJ, Chrastina A, Iwata KR, Zinn KR, Baldwin R, Testa JE, Schnitzer JE: Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung. Nat Biotechnol (2007) 25(3):327-337. • Fluorescently labeled antibodies against APP, a plasma membrane protein specific for the lung endothelium, were injected to target the lung caveolae. The antibodies were pumped from the blood into lung tissue within seconds.
64. Ellmark P, Belov L, Huang P, Lee CS, Solomon MJ, Morgan DK, Christopherson RI: Multiplex detection of surface molecules on colorectal cancers. Proteomics (2006) 6(6):1791-1802. • A thorough analysis of the surface antigens from different single cell populations isolated from colorectal cancers was conducted.
65. Melle C, Bogumil R, Ernst G, Schimmel B, Bleul A, von Eggeling F: Detection and identification of heat shock protein 10 as a biomarker in colorectal cancer by protein profiling. Proteomics (2006) 6(8):2600-2608.
66. Simper-Ronan R, Brilliant K, Flanagan D, Carreiro M, Callanan H, Sabo E, Hixson DC: Cholangiocyte marker-positive and -negative fetal liver cells differ significantly in their ability to regenerate the livers of adult rats exposed to retrosine. Development (2006) 133(21):4269-4279. • Different phenotypically defined subpopulations of fetal liver epithelial cells were isolated by use of an mAb directed against cell-surface developmental epitopes.
67. Laurie NA, Comegys MM, Carreiro MP, Brown JF, Flanagan DL, Brilliant KE, Hixson DC: Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas. Cancer Res (2005) 65(23):11010-11017.
68. Clifton JG, Li X, Reutter W, Hixson DC, Josic D: Comparative proteomics of rat liver and Morris hepatoma 7777 plasma membranes. J Chromatogr B Anal Technol Biomed Life Sci (2007) 849(1-2):293-301.
69. Macario AJL, Conway de Macario E: Sick chaperones, cellular stress and disease. N Engl J Med (2005) 353(14):1489-1501.
70. Liu T, Qian WT, Gritsenko MA, Xiao W, Moldawer LL, Kaushal A, Monroe ME, Varnum SM, Moore RJ, Purvine SO, Maier RV et al: High dynamic range characterization of the trauma patient plasma proteome. Mol Cell Proteomics (2006) 5(10):1899-1913. • An extensive reference database resource to aid investigation of biomarkers for trauma is described.
71. Everberg H, Peterson R, Rak S, Tjerneld F, Emanuelsson C: Aqueous two-phase partitioning for proteomic monitoring of cell surface biomarkers in human peripheral blood mononuclear cells. J Proteome Res (2006) 5(5):1168-1175.
72. Barderas MG, Tunon J, Darde VM, De la Cuesta F, Jimenez-Nacher JJ, Tarin N, Lopez-Bescos L, Egido J, Vivanco F: Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J Proteome Res (2007) 6(2):876-886.
73. Mayr M, Zhang J, Greene AS, Gutterman D, Perloff J, Ping P: Proteomics-based development of biomarkers in cardiovascular disease: Mechanistic, clinical and therapeutic insights. Mol Cell Proteomics (2006) 5(10):1853-1864.
74. Banfi C, Brioschi M, Wait R, Begum S, Gianazza E, Fratto P, Polvani G, Vitali E, Parolari A, Mussoni L, Tremoli E: Proteomic analysis of membrane microdomains derived from both failing and non-failing human hearts. Proteomics (2006) 6(6):1976-1988.
75. Schindler J, Lewandrowski U, Sickmann A, Friauf E, Nothwang HG: Proteomic analysis of brain plasma membranes isolated by affinity two-phase portioning. Mol Cell Proteomics (2006) 5(2):390-400.
76. Coe L, D'Ascenzo M, Relkin NR, Pappin, D, Ross P, Williamson B, Guertin S, Pribil P, Lee KH: 8-Plex quantitation of changes in cerebrospinal fluid protein expression in subjects undergoing intravenous immunoglobulin treatment for Alzheimer's disease. Proteomics (2007) 7(20):3651-3660.
77. D'Ambrosio C, Arena S, Fulcoli G, Scheinfeld MH, Zhou D, D'Adamio L, Scaloni A: Hyperphosphorylation of JNK-interacting protein 1, a protein associated with Alzheimer disease. Mol Cell Proteomics (2006) 5(1):97-113.
78. Wishart TM, Paterson JM, Short DM, Meredith S, Robertson KA, Sutherland C, Cousin MA, Dutia MB, Gillingwater TH: Differential proteomic analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene. Mol Cell Proteomics (2007) 6(8):1318-1330. • A study on the proteomics of neurodegenerative diseases in which changes in non-somatic and axonal compartments of neurons were investigated; changes in the concentrations of proteins that regulate mitochondrial stability and degeneration were detected.
79. Jin J, Hulette C, Wang Y, Zhang T, Pan C, Wadhwa R, Zhang J: Proteomic identification of a stress protein, mortalin/mthsp70/GRP75: Relevance to Parkinson disease. Mol Cell Proteomics (2006) 5(7):1193-1204.
80. Baker MA, Lane DJ, Ly JD, De pinto V, Lawen A: VDAC is a transmembrane NADH-ferricyanate reductase. J Biol Chem (2004) 279(6):4811- 4819.